OpenLegislation

Paragraph 20

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

In the Medicines (Advertising) Regulations 1994f1—

(a)

in paragraph (1) of regulation 2, after the definition of “essential information” there shall be inserted the following definition—

  • ““marketing authorization” means a marketing authorization granted by the European Commission under Council Regulation (EEC) No. 2309/93 or by the licensing authority under the Medicines for Human Use (Marketing Authorizations Etc.) Regulations 1994 and includes a product licence granted by the licensing authority under Part II of the Act;”;

(b)

in paragraph (1) of regulation 3, for the words “product licence” there shall be substituted the words “marketing authorization”; and

(c)

in regulation 4 for the words “product licence” there shall be substituted the words “marketing authorization”;

(d)

in sub-paragraph (l) of paragraph (1) of regulation 9, for the words “product licence” there shall be substituted the words “marketing authorization”;

(e)

in regulation 12, for the words “product licence” there shall be substituted the words “marketing authorization”; and

(f)

in Schedule 2—

(i)

in paragraph 1, for the word “licence” there shall be substituted the word “authorization”;

(ii)

in paragraph 2, for the words “product licence” there shall be substituted the words “marketing authorization”; and

(iii)

in paragraph 5, for the word “licence” there shall be substituted the word “authorization”; and

Annotations

Footnotes

f1

S.I. 1994/1932.